Table 3.
Most frequent adverse events by study group in the safety population (n = 105)
Adverse event* | Miglitol (n = 59) | Placebo (n = 39) | P value |
---|---|---|---|
Abdominal discomfort† | 10 (16.95) | 2 (5.13) | 0.084 |
Diarrhea‡ | 20 (33.90) | 7 (17.95) | 0.117 |
Hypoglycemia‡ | 20 (33.90) | 17 (43.59) | 0.333 |
Other‡ | 9 (15.25) | 13 (33.33) | 0.036§ |
* Data are presented as n (%) of all adverse events compared with ‡ Chi-square or † Fisher exact test
§ P values < 0.05 indicate that the incidence of a specific adverse event was significantly different between the 2 groups